These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1099553)

  • 21. Fibrinolytic split products. A clinicopathological correlative study in adults with lupus glomerulonephritis and various renal diseases.
    Bond RE; Donadio JV; Holley KE; Bowie EJ
    Arch Intern Med; 1973 Aug; 132(2):182-7. PubMed ID: 4719545
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fibrinuria in human renal transplantation].
    Antoine B; Neveu T; Dorrington Ward P
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):744-53. PubMed ID: 4904573
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in blood coagulation in glomerulonephritis].
    Robeva R; Belovezhdov N; Genova V
    Vutr Boles; 1982; 21(6):1-7. PubMed ID: 6219496
    [No Abstract]   [Full Text] [Related]  

  • 24. Human and experimental nephropathies associated with antibodies to tubular basement membrane.
    Rakotoarivony J; Orfila C; Segonds A; Giraud P; Durand D; Dubois C; Mahieu P; Suc JM
    Adv Nephrol Necker Hosp; 1981; 10():187-212. PubMed ID: 6791469
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury.
    Boyce NW; Holdsworth SR
    J Immunol; 1985 Dec; 135(6):3918-21. PubMed ID: 4067309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental glomerulonephritis in the guinea pig. I. Glomerular lesions associated with antiglomerular basement membrane antibody deposits.
    Couser WG; Stilmant M; Lewis EJ
    Lab Invest; 1973 Aug; 29(2):236-43. PubMed ID: 4579664
    [No Abstract]   [Full Text] [Related]  

  • 27. Relapse in anti glomerular basement membrane antibody mediated crescentic glomerulonephritis.
    Wu MJ; Moorthy AV; Beirne GJ
    Clin Nephrol; 1980 Feb; 13(2):97-102. PubMed ID: 7363520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpretation of immunofluorescent patterns in renal diseases.
    Valenzuela R; Deodhar SD
    Pathobiol Annu; 1980; 10():183-221. PubMed ID: 7003493
    [No Abstract]   [Full Text] [Related]  

  • 29. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary fibrin-fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapy.
    Hedner U
    Scand J Clin Lab Invest; 1973 Oct; 32(2):175-82. PubMed ID: 4588514
    [No Abstract]   [Full Text] [Related]  

  • 31. F.D.P. in glomerulonephritis.
    Preston FE; Malia RG; Blackburn EK; Platts M
    Br Med J; 1971 Oct; 4(5780):171-2. PubMed ID: 5113031
    [No Abstract]   [Full Text] [Related]  

  • 32. Idiopathic linear glomerular IgA deposition.
    Fivush B; Melvin T; Solez K; McLean RH
    Arch Pathol Lab Med; 1986 Dec; 110(12):1189-91. PubMed ID: 3778152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early postischaemic renal fibrin deposition and reduction of glomerular filtration rate in the rat: effect of the defibrinating agent Arwin.
    Losonczy G
    Acta Physiol Hung; 1985; 66(2):183-7. PubMed ID: 4050462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of coagulation in glomerular injury.
    Kanfer A
    Toxicol Lett; 1989 Mar; 46(1-3):83-92. PubMed ID: 2650038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmunity and glomerulonephritis.
    Lockwood CM; Bowman C; Bakes D; Pressey A; Dash A
    Adv Nephrol Necker Hosp; 1987; 16():291-306. PubMed ID: 3101428
    [No Abstract]   [Full Text] [Related]  

  • 36. Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis.
    Zoja C; Corna D; Macconi D; Zilio P; Bertani T; Remuzzi G
    Lab Invest; 1990 Jan; 62(1):34-40. PubMed ID: 1688634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice.
    Le Hir M; Haas C; Marino M; Ryffel B
    Lab Invest; 1998 Dec; 78(12):1625-31. PubMed ID: 9881962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fibrinogen (fibrin), factor VIII and factor XIII in children with various renal disease (author's transl)].
    Kamitsuji H; Tani K; Masuyama H; Ichikawa M; Taniguchi A; Takeuchi Y; Iwagaki K
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):23-40. PubMed ID: 6770133
    [No Abstract]   [Full Text] [Related]  

  • 39. [Indices of the blood coagulation and fibrinolytic activity of the urine and renal tissue in glomerulonephritis in children].
    Naumova VI; Enikeeva ZM; Potapova IN; Fonareva LP; Malinina LI
    Pediatriia; 1975 Feb; (2):26-30. PubMed ID: 1228658
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary excretion of heterophile (sheep) haemagglutinins and fibrin-fibrinogen degradation products after renal transplantation and in proliferative glomerulonephritis.
    Hoq MS; Clarkson AR; Anderton JL; Cash JD
    Lancet; 1973 May; 1(7811):1029-31. PubMed ID: 4122111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.